Zusammenfassung der Master-Thesis von Rossella Belleli Efficiency indicators for new drugs approved by the FDA from 2003 toIn the last decades, the drug development costs have increased while the number of new dru

First Page		Document Content
Date: 2016-03-01 06:14:39 Pharmaceutical sciences Medical research Pharmacology Pharmaceutical industry Clinical research Drug discovery Clinical pharmacology Food and Drug Administration Drug development Prescription Drug User Fee Act Orphan drug		Zusammenfassung der Master-Thesis von Rossella Belleli Efficiency indicators for new drugs approved by the FDA from 2003 toIn the last decades, the drug development costs have increased while the number of new dru Add to Reading List Source URL: intern.public-health-edu.ch Download Document from Source Website File Size: 42,00 KB Share Document on Facebook

	Curriculum Vitae Toshifumi Tatsumi Graduate School of Pharmaceutical Sciences, Prof. Kanai Group The University of TokyoHongo, Bunkyo-ku, Tokyo, japan Tel: (+ DocID: 1vqFn - View Document
	JPPT Review Article Developmental Pharmacokinetics in Pediatric Populations Hong Lu, PhD and Sara Rosenbaum, PhD Department of Biomedical and Pharmaceutical Sciences, University of Rhode Island, Kingston, Rhode Island DocID: 1vmzU - View Document
	Institute of Pharmaceutical Sciences Institut für Pharmazeutische Wissenschaften Institute Management DocID: 1veuM - View Document
	Faculty Position in the Graduate School of Pharmaceutical Sciences, Osaka University Outline We are now inviting applications for an Associate Professor (Lecturer) (fulltime, no fixed term) in Laboratory of Bio-Funciton DocID: 1vesi - View Document
	Invites you for “International Conference on the use of National Medicine Policy and Biostatistics in Pharmaceutical Sciences” th DocID: 1vdv9 - View Document